Authors: Piketty, C Jayle, D Leplege, A Castiel, P Ecosse, E Gonzalez-Canali, G Sabatier, B Boulle, N Debuire, B Le Bouc, Y Baulieu, EE Kazatchkine, MD

Citation: C. Piketty et al., Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease, CLIN ENDOCR, 55(3), 2001, pp. 325-330

Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD

Citation: C. Piketty et al., Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz, AIDS, 14(5), 2000, pp. 626-628

Authors: Piketty, C Castiel, P Giral, P Lhomme, JP Boubilley, D Olievenstein, C Lert, F Kazatchkine, MD

Citation: C. Piketty et al., Lack of legal income is strongly associated with an increased risk of AIDSand death in HIV-infected injecting drug users, AIDS CARE, 11(4), 1999, pp. 429-436

Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD

Citation: C. Piketty et al., Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy, AIDS, 13(11), 1999, pp. F71-F77